Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BXRX source : Www.globenewswire.com save search
Delisting of Securities of Sono Group N.V.; Baudax Bio, Inc.; Comera Life Sciences Holdings, Inc.; Missfresh Limited; Rose Hill Acquisition Corporation; Axcella Health; Zivo Bioscience, Inc.; Sonic Foundry, Inc.; Mobiquity Technologies, Inc.; Cuentas, Inc.; micromobility.com Inc.; Harbor Custom Development, Inc.; Nogin, Inc.; Disruptive Acquisition Corporation I; Ebix, Inc.; and Aurora Technology Acquisition Corp. from The Nasdaq Stock Market
Published: 2024-02-13 (Crawled : 21:00) - globenewswire.com
SEVCQ | $0.036 20K
|
n/a
|
| O: -7.69%
H: 46.67%
C: 11.83%
CMRA | $0.0595 79K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -8.0%
MOBQ | $0.6998 11K
|
|
| O: -14.63%
H: 17.14%
C: 8.57%
NDAQ | $60.0 -0.32% 640K
|
Finance
|
| O: 0.65%
H: 0.23%
C: -0.45%
nasdaq rose life corporation group acquisition sciences technology market
Baudax Bio Announces Corporate Update
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 25.86%
H: 1.16%
C: -18.31%
update
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
Published: 2023-09-28 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 87.57%
H: 38.62%
C: -19.67%
ti-168 fda drug granted treatment designation
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
Published: 2023-09-07 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.04%
H: 2.56%
C: 1.28%
conference global
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Published: 2023-08-23 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 6.03%
H: 0.0%
C: -4.53%
distribution
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-08-17 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -6.11%
H: 5.53%
C: 0.4%
nasdaq direct offering
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -3.48%
H: 0.0%
C: 0.0%
business update financial results
Baudax Bio Acquires TeraImmune, Inc.
Published: 2023-06-30 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 23.03%
H: 123.42%
C: 82.81%
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-06-07 (Crawled : 13:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 7.16%
H: 5.23%
C: -2.57%
bx1000 positive trial results phase 2
Baudax Bio Announces Date of Reconvened Annual Meeting
Published: 2023-06-06 (Crawled : 13:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.85%
H: 2.91%
C: 1.8%
meeting
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
Published: 2023-05-12 (Crawled : 12:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 2.94%
H: 1.2%
C: -3.14%
business update financial results
Baudax Bio to Present at the Sidoti Virtual Investor Conference
Published: 2023-05-03 (Crawled : 20:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 4.61%
H: 0.0%
C: -1.85%
conference
Baudax Bio Announces Closing of $4 Million Public Offering
Published: 2023-05-01 (Crawled : 22:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.31%
H: 1.62%
C: -4.87%
offering
Baudax Bio Announces Pricing of $4 Million Public Offering
Published: 2023-04-27 (Crawled : 02:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -52.0%
H: 7.11%
C: -7.9%
offering
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 63.83%
H: 12.66%
C: -32.14%
bx1000 trial results phase 2
Baudax Bio Announces Pricing of $5 Million Public Offering
Published: 2022-12-02 (Crawled : 20:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
| Email alert
Add to watchlist
offering
Baudax Bio Announces 1-for-40 Reverse Stock Split
Published: 2022-11-30 (Crawled : 22:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: -22.81%
Baudax Bio Announces Closing of $6.2 Million Public Offering
Published: 2022-09-01 (Crawled : 19:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.82%
H: 5.6%
C: -5.05%
offering
Baudax Bio Announces Pricing of $6.2 Million Public Offering
Published: 2022-08-30 (Crawled : 03:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -40.03%
H: 7.98%
C: -5.07%
offering
Baudax Bio Announces $2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2022-05-17 (Crawled : 00:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -28.51%
H: 1.56%
C: -3.81%
offering nasdaq
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.